Orum Therapeutics Revenue and Competitors

Daejeon, --Select--

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Orum Therapeutics's estimated annual revenue is currently $4.2M per year.(i)
  • Orum Therapeutics's estimated revenue per employee is $77,500

Employee Data

  • Orum Therapeutics has 54 Employees.(i)
  • Orum Therapeutics grew their employee count by -19% last year.

Orum Therapeutics's People

NameTitleEmail/Phone
1
COO/CFOReveal Email/Phone
2
VP, Head Business DevelopmentReveal Email/Phone
3
Head Business DevelopmentReveal Email/Phone
4
Head ChemistryReveal Email/Phone
5
Head BiologyReveal Email/Phone
6
Associate Director, ImmunologyReveal Email/Phone
7
Associate Director In Vivo PharmacologyReveal Email/Phone
8
Chief Medical OfficerReveal Email/Phone
9
Associate Director, Clinical OperationsReveal Email/Phone
10
Laboratory Operations ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.2M54-19%N/AN/A
Add Company

What Is Orum Therapeutics?

Orum Therapeutics is a private biotech developing next-generation TPD technologies. Orum's novel and proprietary next generation targeted protein degradation (TPD) platform, TPD2 AnDC (Antibody neoDegrader Conjugate), enables tumor-specific targeting for multiple indications. Orum was founded in 2016 and has labs and offices operating out of Daejeon, South Korea, and Cambridge, MA, US.

keywords:N/A

N/A

Total Funding

54

Number of Employees

$4.2M

Revenue (est)

-19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.4M544%N/A
#2
$7.6M764%N/A